Vanda Pharmaceuticals | VNDA - Marktkapitalisierung

Aktienkurs
6.85
Täglich Wechseln
-0.16 -2.21%
Monatlich
-17.33%
Jährlich
42.31%
Q1 Prognose
6.91




Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Akebia Therapeutics USD 312M 115M 2026-03
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Anika Therapeutics USD 210M 71M 2026-03
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 475M 410M 2026-03
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 133M 105M 2026-03
Insmed USD 37.12B 6.68B 2025-12
J&J USD 500.24B 67.44B 2025-12
Lexicon Pharmaceuticals USD 416M 2M 2026-03
Merck USD 261.26B 51.62B 2025-12
Novartis USD 303.66B 40.58B 2026-03
Pfizer USD 153.96B 12.4B 2026-03
PTC Therapeutics USD 6.1B 1.22B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12
Veracyte USD 3.33B 627M 2025-12